Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 38, Issue 1, 2018, Pages 49-63

  Nguyen, My Anh ^a,b   Karunakaran, Denuja ^a   Geoffrion, Michèle ^a   Cheng, Henry S ^c   Tandoc, Kristofferson ^a   Perisic Matic, Ljubica ^d   Hedin, Ulf ^c   Maegdefessel, Lars ^e   Fish, Jason E ^d   Rayner, Katey J ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d KAROLINSKA INSTITUTE   (Sweden)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

atherosclerosis; exosomes; extracellular vesicles; macrophage; microRNA; migration

Indexed keywords

ANTIGEN; ELAV LIKE PROTEIN 1; HUMAN ANTIGEN R; INSULIN LIKE GROWTH FACTOR 2 MRNA BINDING PROTEIN 1; MESSENGER RNA; MICRORNA; MICRORNA 128; MICRORNA 146A; MICRORNA 185; MICRORNA 365; MICRORNA 503; OXIDIZED LOW DENSITY LIPOPROTEIN; SMALL INTERFERING RNA; SOMATOMEDIN; UNCLASSIFIED DRUG; CRD-BP PROTEIN, MOUSE; ELAVL1 PROTEIN, MOUSE; MIRN146 MICRORNA, MOUSE; RNA BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROGENESIS; BIOINFORMATICS; BLOOD VESSEL WALL; CELL ADHESION; CELL COMMUNICATION; CELL MIGRATION; CONTROLLED STUDY; EXOSOME; GENE EXPRESSION PROFILING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; APOLIPOPROTEIN E KNOCKOUT MOUSE; ATHEROSCLEROSIS; C57BL MOUSE; CELL MOTION; COCULTURE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PERITONEUM MACROPHAGE; RAW 264.7 CELL LINE; SECRETORY PATHWAY; SECRETORY VESICLE; SIGNAL TRANSDUCTION; THP-1 CELL LINE;

ANIMALS; ATHEROSCLEROSIS; CELL MOVEMENT; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; ELAV-LIKE PROTEIN 1; EXTRACELLULAR VESICLES; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT, APOE; MICRORNAS; RAW 264.7 CELLS; RNA-BINDING PROTEINS; SECRETORY PATHWAY; SECRETORY VESICLES; SIGNAL TRANSDUCTION; THP-1 CELLS;

EID: 85039435686     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.117.309795     Document Type: Article

References (65)

1. Kjenseth A, Fykerud T, Rivedal E, Leithe E. Regulation of gap junction intercellular communication by the ubiquitin system. Cell Signal. 2010;22:1267-1273. doi: 10.1016/j.cellsig.2010.03.005
2. Denef C. Paracrinicity: the story of 30 years of cellular pituitary crosstalk. J Neuroendocrinol. 2008;20:1-70. doi: 10.1111/j.1365-2826.2007.01616.x
3. Singer SJ. Intercellular communication and cell-cell adhesion. Science. 1992;255:1671-1677
4. Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood. 2001;97:3075-3085
5. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006;20:1487-1495. doi: 10.1038/sj.leu.2404296
6. Keller S, Sanderson MP, Stoeck A, Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett. 2006;107:102-108. doi: 10.1016/j.imlet.2006.09.005
7. Bobrie A, Colombo M, Raposo G, Thery C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 2011;12:1659-1668. doi: 10.1111/j.1600-0854.2011.01225.x
8. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010;78:838-848. doi: 10.1038/ki.2010.278
9. Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012;21(1):R125-R134. doi: 10.1093/hmg/dds317
10. Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 2012;22:125-132. doi: 10.1016/j.tcb.2011.12.001
11. Bhatnagar S, Shinagawa K, Castellino FJ, Schorey JS. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood. 2007;110:3234-3244. doi: 10.1182/blood-2007-03-079152
12. McDonald MK, Tian Y, Qureshi RA, Gormley M, Ertel A, Gao R, Aradillas Lopez E, Alexander GM, Sacan A, Fortina P, Ajit SK. Functional significance of macrophage-derived exosomes in inflammation and pain. Pain. 2014;155:1527-1539. doi: 10.1016/j.pain.2014.04.029
13. Ismail N, Wang Y, Dakhlallah D, Moldovan L, Agarwal K, Batte K, Shah P, Wisler J, Eubank TD, Tridandapani S, Paulaitis ME, Piper MG, Marsh CB. Macrophage microvesicles induce macrophage differentiation and MIR-223 transfer. Blood. 2013;121:984-995. doi: 10.1182/ blood-2011-08-374793
14. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241. doi: 10.1038/35025203
15. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145:341-355. doi: 10.1016/j.cell.2011.04.005
16. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013;13:709-721. doi: 10.1038/ nri3520
17. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D, Tabas I. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol. 2003;5:781-792. doi: 10.1038/ncb1035
18. Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357-1361. doi: 10.1038/nature08938
19. Randolph GJ. Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis. Curr Opin Lipidol. 2008;19:462-468. doi: 10.1097/MOL.0b013e32830d5f09
20. van Gils JM, Derby MC, Fernandes LR, et al. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat Immunol. 2012;13:136-143. doi: 10.1038/ ni.2205
21. Wanschel A, Seibert T, Hewing B, Ramkhelawon B, Ray TD, van Gils JM, Rayner KJ, Feig JE, O'Brien ER, Fisher EA, Moore KJ. Neuroimmune guidance cue semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention. Arterioscler Thromb Vasc Biol. 2013;33:886-893. doi: 10.1161/ATVBAHA.112.300941
22. Krohn JB, Hutcheson JD, Martinez-Martinez E, Aikawa E. Extracellular vesicles in cardiovascular calcification: expanding current paradigms. J Physiol. 2016;594:2895-2903. doi: 10.1113/JP271338
23. Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012;82:1024-1032. doi: 10.1038/ki.2012.256
24. Rekker K, Saare M, Roost AM, Kubo AL, Zarovni N, Chiesi A, Salumets A, Peters M. Comparison of serum exosome isolation methods for microRNA profiling. Clin Biochem. 2014;47:135-138. doi:, 10.1016/j. clinbiochem.2013.10.020
25. Hu G, Drescher KM, Chen XM. Exosomal miRNAs: biological properties and therapeutic potential. Front Genet. 2012;3:56. doi: 10.3389/ fgene.2012.00056
26. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010;285:17442-17452. doi: 10.1074/jbc. M110.107821
27. Lu TP, Lee CY, Tsai MH, Chiu YC, Hsiao CK, Lai LC, Chuang EY. miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets. PLoS One. 2012;7:e42390. doi: 10.1371/ journal.pone.0042390
28. Harry BL, Sanders JM, Feaver RE, Lansey M, Deem TL, Zarbock A, Bruce AC, Pryor AW, Gelfand BD, Blackman BR, Schwartz MA, Ley K. Endothelial cell PECAM-1 promotes atherosclerotic lesions in areas of disturbed flow in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2008;28:2003-2008. doi: 10.1161/ATVBAHA.108.164707
29. Tsoyi K, Jang HJ, Nizamutdinova IT, Park K, Kim YM, Kim HJ, Seo HG, Lee JH, Chang KC. PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K/Akt/GSK-3B/GATA-6 signaling pathways in TNF-A-activated human endothelial cells. Atherosclerosis. 2010;213:115-121. doi: 10.1016/j.atherosclerosis.2010.07.061
30. van Gils JM, Ramkhelawon B, Fernandes L, Stewart MC, Guo L, Seibert T, Menezes GB, Cara DC, Chow C, Kinane TB, Fisher EA, Balcells M, Alvarez-Leite J, Lacy-Hulbert A, Moore KJ. Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions. Arterioscler Thromb Vasc Biol. 2013;33:911-919. doi: 10.1161/ATVBAHA.112.301155
31. Llodra J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA. 2004;101:11779-11784. doi: 10.1073/pnas.0403259101
32. Bellingan GJ, Caldwell H, Howie SE, Dransfield I, Haslett C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol. 1996;157:2577-2585
33. Park YM, Febbraio M, Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest. 2009;119:136-145. doi: 10.1172/JCI35535
34. Dormoy-Raclet V, Menard I, Clair E, Kurban G, Mazroui R, Marco S, von Roretz C, Pause A, Gallouzi IE. The RNA-binding protein HuR promotes cell migration and cell invasion by stabilizing the beta-actin mRNA in a U-rich-element-dependent manner. Mol Cell Biol. 2007;27:5365-5380. doi: 10.1128/MCB.00113-07
35. Stohr N, Huttelmaier S. IGF2BP1: a post-transcriptional "driver" of tumor cell migration. Cell Adh Migr. 2012;6:312-318. doi: 10.4161/ cam.20628
36. Cheng HS, Sivachandran N, Lau A, Boudreau E, Zhao JL, Baltimore D, Delgado-Olguin P, Cybulsky MI, Fish JE. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med. 2013;5:1017-1034. doi: 10.1002/emmm.201202318
37. Feinberg MW, Moore KJ. MicroRNA regulation of atherosclerosis. Circ Res. 2016;118:703-720. doi: 10.1161/CIRCRESAHA.115.306300
38. Hulsmans M, Holvoet P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res. 2013;100:7-18. doi: 10.1093/cvr/cvt161
39. Chistiakov DA, Orekhov AN, Bobryshev YV. Extracellular vesicles and atherosclerotic disease. Cell Mol Life Sci. 2015;72:2697-2708. doi: 10.1007/s00018-015-1906-2
40. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Koppel T, Jahantigh MN, Lutgens E, Wang S, Olson EN, Schober A, Weber C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009;2:ra81. doi: 10.1126/scisignal.2000610
41. Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJ, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler S. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14:249-256. doi: 10.1038/ncb2441
42. Ramakrishnan DP, Hajj-Ali RA, Chen Y, Silverstein RL. Extracellular vesicles activate a CD36-dependent signaling pathway to inhibit microvascular endothelial cell migration and tube formation. Arterioscler Thromb Vasc Biol. 2016;36:534-544. doi: 10.1161/ATVBAHA.115.307085
43. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, Kuziel WA, Ahuja SS. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania majorresistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med. 2000;192:205-218
44. Jimenez F, Quinones MP, Martinez HG, Estrada CA, Clark K, Garavito E, Ibarra J, Melby PC, Ahuja SS. CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. J Immunol. 2010;184:5571-5581. doi: 10.4049/jimmunol.0803494
45. Chen Y, Kennedy DJ, Ramakrishnan DP, Yang M, Huang W, Li Z, Xie Z, Chadwick AC, Sahoo D, Silverstein RL. Oxidized LDL-bound CD36 recruits an Na/K-ATPase-Lyn complex in macrophages that promotes atherosclerosis. Sci Signal. 2015;8:ra91. doi: 10.1126/scisignal.aaa9623
46. Dong R, Lu JG, Wang Q, He XL, Chu YK, Ma QJ. Stabilization of snail by HuR in the process of hydrogen peroxide induced cell migration. Biochem Biophys Res Commun. 2007;356:318-321. doi: 10.1016/j. bbrc.2007.02.145
47. Stohr N, Kohn M, Lederer M, Glass M, Reinke C, Singer RH, Huttelmaier S. IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling. Genes Dev. 2012;26:176-189. doi: 10.1101/gad.177642.111
48. Cao C, Lawrence DA, Strickland DK, Zhang L. A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. Blood. 2005;106:3234-3241. doi: 10.1182/blood-2005-03-1288
49. Singh PP, Smith VL, Karakousis PC, Schorey JS. Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo. J Immunol. 2012;189:777-785. doi: 10.4049/jimmunol.1103638
50. Walters SB, Kieckbusch J, Nagalingam G, Swain A, Latham SL, Grau GE, Britton WJ, Combes V, Saunders BM. Microparticles from mycobacteriainfected macrophages promote inflammation and cellular migration. J Immunol. 2013;190:669-677. doi: 10.4049/jimmunol.1201856
51. Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140:871-882. doi: 10.1016/j.cell.2010.02.029
52. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-659. doi: 10.1038/ncb1596
53. Zhang Y, Liu D, Chen X, et al. Secreted monocytic MIR-150 enhances targeted endothelial cell migration. Mol Cell. 2010;39:133-144. doi: 10.1016/j.molcel.2010.06.010
54. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M, Sanchez-Madrid F. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980. doi: 10.1038/ ncomms3980
55. McKenzie AJ, Hoshino D, Hong NH, Cha DJ, Franklin JL, Coffey RJ, Patton JG, Weaver AM. KRAS-MEK signaling controls Ago2 sorting into exosomes. Cell Rep. 2016;15:978-987. doi: 10.1016/j. celrep.2016.03.085
56. Shurtleff M, Karfilis KV, Temoche-Diaz M, Ri S, Schekman R. Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cellfree reaction. Elife. 2016; 5:e19276
57. Lougheed M, Lum CM, Ling W, Suzuki H, Kodama T, Steinbrecher U. High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J Biol Chem. 1997;272:12938-12944
58. Wagschal A, Najafi-Shoushtari SH, Wang L, et al. Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis. Nat Med. 2015;21:1290-1297. doi: 10.1038/nm.3980
59. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaBdependent induction of microRNA MIR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006;103:12481-12486. doi: 10.1073/pnas.0605298103
60. Saba R, Sorensen DL, Booth SA. MicroRNA-146a: a dominant, negative regulator of the innate immune response. Front Immunol. 2014;5:578. doi: 10.3389/fimmu.2014.00578
61. Li K, Ching D, Luk FS, Raffai RL. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-kB-driven inflammation and atherosclerosis. Circ Res. 2015;117:e1-e11. doi: 10.1161/CIRCRESAHA.117.305844
62. Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu J, Sun Z, Shen WF. MIR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett. 2011;585:854-860. doi: 10.1016/j.febslet.2011.02.009
63. Cheng HS, Besla R, Li A, et al. Paradoxical suppression of atherosclerosis in the absence of microRNA-146a. Circ Res. 2017;121(4):354-367. doi: 10.1161/CIRCRESAHA.116.310529
64. Raitoharju E, Lyytikainen LP, Levula M, Oksala N, Mennander A, Tarkka M, Klopp N, Illig T, Kahonen M, Karhunen PJ, Laaksonen R, Lehtimaki T. MIR-21, MIR-210, MIR-34a, and MIR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis. 2011;219:211-217. doi: 10.1016/j.atherosclerosis.2011.07.020
65. Xiong XD, Cho M, Cai XP, Cheng J, Jing X, Cen JM, Liu X, Yang XL, Suh Y. A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutat Res. 2014;761:15-20. doi: 10.1016/j.mrfmmm.2014.01.001